Search results
Merck's CEO to succeed Ken Frazier as chairman
Reuters via Yahoo Finance· 2 years agoFrazier, who has been a key growth driver of the drugmaker for decades, joined Merck around 30 years ago and became the first Black CEO of a major drug...
Drugmakers' shares stabilise after Zantac litigation slump
Reuters via Yahoo Finance· 2 years agoShares in GSK, Sanofi, Haleon and Pfizer began to recover on Friday after the companies said that...
Top FDA official Woodcock to retire early next year
BioPharma Dive via Yahoo Finance· 7 months agoThe 37-year veteran helmed the agency’s pandemic response, and was a key decision-maker in controversial calls on opioids, an Alzheimer's therapy and...
Haleon believes it is not liable for any potential Zantac liabilities
Reuters via Yahoo Finance· 2 years agoLONDON (Reuters) -Haleon believes it is not liable for any claims that may arise from U.S....
New GSK maintains strong start, but Zantac litigation looms large
Reuters via Yahoo Finance· 2 years ago(Reuters) -GSK raised its 2022 forecast for the second time this year, after third-quarter earnings...
Could AI put an end to animal testing?
BBC via Yahoo News· 3 days agoAI may one day mean that animals are not required for medical testing [Getty Images] From animal lovers to laboratory technicians, no-one enjoys...
GSK, Sanofi shares soar as Zantac litigation fears abate
Reuters via Yahoo Finance· 2 years agoShares of GSK and Sanofi surged on Wednesday, adding more than $20 billion in combined value in...
GSK, Sanofi and Haleon shares slump on Zantac litigation concerns
Reuters via Yahoo News· 2 years agoLONDON (Reuters) -Shares in GSK, Sanofi and Haleon fell sharply on Thursday, following declines...
UPDATE 2-GSK lifts earnings view again after forecast-beating quarter
Reuters via Yahoo Finance· 2 years ago* Q3 adjusted EPS 46.9 pence vs forecast 40.1 pence * Sees 2022 adj op profit up 15-17% vs up 13-15% before (Adds details, background) By Natalie Grover Nov 2 (Reuters) - GSK eclipsed analyst ...
UPDATE 2-Haleon rejects Zantac indemnification requests from GSK, Pfizer
Reuters via Yahoo Finance· 2 years agoHaleon on Tuesday said it had notified GSK and Pfizer that it had rejected their requests for indemnification in relation to U.S.-based litigation over the heartburn drug, Zantac. More than ...
